128 related articles for article (PubMed ID: 2904671)
1. Distinguishable effects of intrathecal dynorphins, somatostatin, neurotensin and s-calcitonin on nociception and motor function in the rat.
Spampinato S; Romualdi P; Candeletti S; Cavicchini E; Ferri S
Pain; 1988 Oct; 35(1):95-104. PubMed ID: 2904671
[TBL] [Abstract][Full Text] [Related]
2. Characterization of dynorphin A-induced antinociception at spinal level.
Spampinato S; Candeletti S
Eur J Pharmacol; 1985 Mar; 110(1):21-30. PubMed ID: 2861098
[TBL] [Abstract][Full Text] [Related]
3. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. I. Injection procedures modify pharmacological responses.
Long JB; Mobley WC; Holaday JW
J Pharmacol Exp Ther; 1988 Sep; 246(3):1158-66. PubMed ID: 2901486
[TBL] [Abstract][Full Text] [Related]
4. Comparative study of the analgesic and paralytic effects induced by intrathecal dynorphin a in rats.
Xue JC; Yu YX; Han JS; Jen MF
Int J Neurosci; 1995 May; 82(1-2):83-93. PubMed ID: 7591518
[TBL] [Abstract][Full Text] [Related]
5. Neurological dysfunction after intrathecal injection of dynorphin A (1-13) in the rat. II. Nonopioid mechanisms mediate loss of motor, sensory and autonomic function.
Long JB; Petras JM; Mobley WC; Holaday JW
J Pharmacol Exp Ther; 1988 Sep; 246(3):1167-74. PubMed ID: 2901487
[TBL] [Abstract][Full Text] [Related]
6. Antinociception and paralysis induced by intrathecal dynorphin A.
Herman BH; Goldstein A
J Pharmacol Exp Ther; 1985 Jan; 232(1):27-32. PubMed ID: 2856940
[TBL] [Abstract][Full Text] [Related]
7. N-methyl-D-aspartate receptor-mediated changes in thermal nociception: allosteric modulation at glycine and polyamine recognition sites.
Kolhekar R; Meller ST; Gebhart GF
Neuroscience; 1994 Dec; 63(4):925-36. PubMed ID: 7535397
[TBL] [Abstract][Full Text] [Related]
8. Intrathecal dynorphin(1-13) results in an irreversible loss of the tail-flick reflex in rats.
Caudle RM; Isaac L
Brain Res; 1987 Dec; 435(1-2):1-6. PubMed ID: 2892573
[TBL] [Abstract][Full Text] [Related]
9. Intrathecal somatostatin, somatostatin analogs, substance P analog and dynorphin A cause comparable neurotoxicity in rats.
Gaumann DM; Grabow TS; Yaksh TL; Casey SJ; Rodriguez M
Neuroscience; 1990; 39(3):761-74. PubMed ID: 1711172
[TBL] [Abstract][Full Text] [Related]
10. Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice.
Kuzmin A; Madjid N; Terenius L; Ogren SO; Bakalkin G
Neuropsychopharmacology; 2006 Sep; 31(9):1928-37. PubMed ID: 16292317
[TBL] [Abstract][Full Text] [Related]
11. Intrathecal and epidural somatostatin in rats: can antinociception, motor effects and neurotoxicity be separated?
Mollenholt P; Post C; Paulsson I; Rawal N
Pain; 1990 Dec; 43(3):363-370. PubMed ID: 1981389
[TBL] [Abstract][Full Text] [Related]
12. Antinociceptive and morphine modulatory actions of spinal orphanin FQ.
Jhamandas KH; Sutak M; Henderson G
Can J Physiol Pharmacol; 1998 Mar; 76(3):314-24. PubMed ID: 9673795
[TBL] [Abstract][Full Text] [Related]
13. Characterization of the antinociception produced by intrathecally administered muscarinic agonists in rats.
Iwamoto ET; Marion L
J Pharmacol Exp Ther; 1993 Jul; 266(1):329-38. PubMed ID: 8101218
[TBL] [Abstract][Full Text] [Related]
14. [Intrathecal co-administration of kappa opioid receptor agonists and NMDA receptor antagonists induces synergistic analgesia in rats].
Li FC; Sun XJ; Hu WH; Jen MF
Yao Xue Xue Bao; 1994; 29(12):881-6. PubMed ID: 7709739
[TBL] [Abstract][Full Text] [Related]
15. Dynorphins other than dynorphin A(1-17) lack spinal antianalgesic activity but do act on dynorphin A(1-17) receptors.
Rady JJ; Fujimoto JM; Tseng LF
J Pharmacol Exp Ther; 1991 Dec; 259(3):1073-80. PubMed ID: 1684812
[TBL] [Abstract][Full Text] [Related]
16. Effects of synchronous or asynchronous electroacupuncture stimulation with low versus high frequency on spinal opioid release and tail flick nociception.
Wang Y; Zhang Y; Wang W; Cao Y; Han JS
Exp Neurol; 2005 Mar; 192(1):156-62. PubMed ID: 15698629
[TBL] [Abstract][Full Text] [Related]
17. Dynorphin-related peptides cause motor dysfunction in the rat through a non-opiate action.
Faden AI; Jacobs TP
Br J Pharmacol; 1984 Feb; 81(2):271-6. PubMed ID: 6142741
[TBL] [Abstract][Full Text] [Related]
18. Endogenous dynorphin modulates calcium-mediated antinociception in mice.
Smith FL; Dewey WL
Pharmacol Biochem Behav; 1993 Jun; 45(2):383-91. PubMed ID: 8101006
[TBL] [Abstract][Full Text] [Related]
19. Mixed opioid/nonopioid effects of dynorphin and dynorphin related peptides after their intrathecal injection in rats.
Przewłocki R; Shearman GT; Herz A
Neuropeptides; 1983 Jan; 3(3):233-40. PubMed ID: 16229165
[TBL] [Abstract][Full Text] [Related]
20. Dynorphin A and related peptides administered intrathecally in the rat: a search for putative kappa opiate receptor activity.
Stevens CW; Yaksh TL
J Pharmacol Exp Ther; 1986 Sep; 238(3):833-8. PubMed ID: 2875172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
